COMPOSITION FOR THE TREATMENT OF OBESITY AND HYPERLIPIDAEMIA

摘要

The invention relates to the pharmaceutical industry and, more specifically, the industry involved in the manufacture of pharmaceutical products used to reduce weight and to treat hyperlipidaemia. The invention is advantageous over similar existing compositions in that it eliminates the collateral effects normally caused by ingestion of a lipase inhibitor. According to the invention, both the lipase inhibitor component and the fat-trapper are optimised, using a suitable composition for, and very small quantities of each of the components. The invention relates to a composition for the treatment of obesity and hyperlipidaemia, which is characterised in that it combines a lipase inhibitor and a fat-trapper compound.